Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Cell

• Publication date

  1989-01-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0092-8674(89)90982-3PMID 2783386
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthetic peptides as antigens and competitors in recognition by H-2- restricted cytolytic T cells specific for HLA

  1988cited by this paper
• T cells can distinguish between allogeneic major histocompatibility complex products on different cell types

  1988cited by this paper
• Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor.

  1988cited by this paper
• An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

  1988cited by this paper
• Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes.

  1988cited by this paper
• Microrecombinations generate sequence diversity in the murine major histocompatibility complex: analysis of the Kbm3, Kbm4, Kbm10, and Kbm11 mutants

  1988cited by this paper
• Three-dimensional structure of antibodies.

  1988cited by this paper
• T cell activation by purified, soluble, class I MHC molecules. Requirement for polyvalency.

  1988cited by this paper
• Functional and Molecular Aspects of Human T Lymphocyte Activation via T3‐Ti and Tl1 Pathways

  1987cited by this paper
• Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the α2 domain of HLA–A2

  1987cited by this paper
• Structure of the human class I histocompatibility antigen, HLA-A2

  1987cited by this paper
• The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides

  1987cited by this paper
• Cytotoxic T cell activation by class I protein on cell-size artificial membranes: antigen density and Lyt-2/3 function.

  1987cited by this paper
• Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2.

  1987cited by this paper
• Quantitative analysis of the T cell response to antigen and planar membranes containing purified Ia molecules.

  1987cited by this paper
• Functional and molecular aspects of human T lymphocyte activation via T3-Ti and T11 pathways.

  1987cited by this paper
• On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes

  1987cited by this paper
• HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes

  1987cited by this paper
• Comparison of the primary structure of class I molecules

  1987cited by this paper
• Comparison of the primary structure of class I molecules

  1987cited by this paper
• Cytotoxic T lymphocytes against a soluble protein

  1987cited by this paper
• Interaction of peptide antigens and class II major histocompatibility complex antigens

  1986cited by this paper
• H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide

  1986cited by this paper
• Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants.

  1986cited by this paper
• The requirements for antigen multivalency in class I antigen recognition and triggering of primed precursor cytolytic T lymphocytes.

  1986cited by this paper
• The role of class II MHC molecules in the activation of class I-reactive T cell hybridomas.

  1986cited by this paper
• The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

  1986cited by this paper
• The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response.

  1986cited by this paper
• Immune response (Ir) genes of the murine major histocompatibility complex.

  1986cited by this paper
• Genetic engineering of an H-2Dd/Q10b chimeric histocompatibility antigen: purification of soluble protein from transformant cell supernatants.

  1986cited by this paper
• Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications.

  1986cited by this paper
• Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

  1986cited by this paper
• Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level.

  1985cited by this paper
• T-cell activation by peptide antigen: effect of peptide sequence and method of antigen presentation.

  1985cited by this paper
• Binding of immunogenic peptides to Ia histocompatibility molecules

  1985cited by this paper
• High determinant density may explain the phenomenon of alloreactivity.

  1984cited by this paper
• Allogeneic stimulation of cytotoxic T cells by supported planar membranes.

  1984cited by this paper
• Domain interactions of H–2 class I antigens alter cytotoxic T-cell recognition sites

  1984cited by this paper
• Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

  1984cited by this paper
• Serological analysis of H-2 mutations using monoclonal antibodies.

  1984cited by this paper
• The DNA sequence of the H‐2kb gene: evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibilty antigens.

  1983cited by this paper
• Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens

  1982cited by this paper
• Secondary cytolytic T lymphocyte stimulation by purified H-2Kk in liposomes.

  1981cited by this paper
• Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens

  1980cited by this paper
• Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

  1980cited by this paper
• Calculation of average antibody affinity in anti-hapten sera from data obtained by competitive radioimmunoassay.

  1980cited by this paper
• MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

  1979cited by this paper
• T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes

  1979cited by this paper
• Lymphocyte specificity to protein antigens. II. Fine specificity of T- cell activation with cytochrome c and derived peptides as antigenic probes

  1979cited by this paper
• Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles.

  1978cited by this paper
• Genetic control of the T lymphocyte proliferative response to staphylococcal nuclease: evidence for multiple MHC-linked Ir gene control.

  1978cited by this paper
• Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

  1977cited by this paper

• Investigation of the Impact of Streptococcus pneumoniae on A549 Pneumocytes

  2019cites this paper
• Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application

  2017cites this paper
• Bioconjugate Strategies for the Induction of Antigen-Specific Tolerance in Autoimmune Diseases.

  2017cites this paper
• MHC-Ig Dimers: The next Frontier in Transplantation Immunology

  2015cites this paper
• The Intricate Behavior of T Cells

  2014cites this paper
• Concise Review: Immunologic Lessons From Solid Organ Transplantation for Stem Cell‐Based Therapies

  2013cites this paper
• T cell triggering: insights from 2D kinetics analysis of molecular interactions

  2012cites this paper
• Alloreactivity: An Old Puzzle Revisited

  2012cites this paper
• MHC class I-presented lung cancer-associated tumor antigens identified by immunoproteomics analysis are targets for cancer-specific T cell response.

  2011cites this paper
• T Cells Enhance Stem-Like Properties and Conditional Malignancy in Gliomas

  2010cites this paper
• MHC restriction and allogeneic immune responses

  2008cites this paper
• of and CD8 + T cells in allorecognition: lessons from corneal transplantation

  2006cites this paper
• A Divalent Human Leukocyte Antigen-B7 Fusion-Protein Up-regulates CD25 and CD69 in Alloreactive CD8+ T Cells Bypassing CD28 Costimulation

  2006cites this paper
• Soluble MHC-Peptide Complexes Containing Long Rigid Linkers Abolish CTL-Mediated Cytotoxicity1

  2006cites this paper
• Rapid Death of CD 8 Soluble MHC-Peptide Complexes Induce

  2005cites this paper
• Soluble MHC-Peptide Complexes Induce Rapid Death of CD8+ CTL1

  2005cites this paper
• MHC Restriction and Allogeneic Immune Response

  2005cites this paper
• Membrane-bound and water-soluble nonclassical class I MHC antigens on rat placenta

  2004cites this paper
• Analysis of novel residues of class I involved in recognition by alloreactive T cells

  2004cites this paper
• Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides*

  2003cites this paper
• Rolle von löslichen MHC-Klasse I-Molekülen bei der Apoptose sensibilisierter T-Lymphozyten

  2003cites this paper
• Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor‐specific antigens

  2002cites this paper
• Rational design and development of RDP58.

  2002cites this paper
• Alloreactivity and apoptosis in graft rejection and transplantation tolerance

  2000cites this paper
• Inhibition of Epstein–Barr virus (EBV)‐specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro

  2000cites this paper
• Cytotoxic cells : basic mechanisms and medical applications

  2000cites this paper
• Soluble HLA Class I and Fas Ligand Molecules in Blood Components and their Role in the Immunomodulatory Effects of Blood Transfusions

  2000cites this paper
• Information transfer at the immunological synapse.

  2000cites this paper
• The Immune Response to Alloantigens

  2000cites this paper
• Mechanisms of induction of tolerance to organ allografts.

  2000cites this paper
• Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes

  2000cites this paper
• Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions.

  1999cites this paper
• An allosteric mechanism controls antigen presentation by the H-2K(b) complex.

  1999cites this paper
• Adhesion energy of receptor-mediated interaction measured by elastic deformation.

  1999influential citation
• Beta2-micro-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta2-micro-associated HLA class I heavy chain levels and HLA phenotype.

  1999cites this paper
• Soluble HLA Class I, HLA Class II, and Fas Ligand in Blood Components: A Possible Key to Explain the Immunomodulatory Effects of Allogeneic Blood Transfusions

  1999cites this paper
• β2‐μ‐free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with β2‐μ‐associated HLA class I heavy chain levels and HLA phenotype

  1999cites this paper
• Mechanisms of CD8beta-mediated T cell response enhancement: interaction with MHC class I/beta2-microglobulin and functional coupling to TCR/CD3.

  1998cites this paper
• Induction of tolerance in rodent cardiac allotransplantation using an MHC class I-derived peptide and cyclosporin A.

  1998cites this paper
• Characterization and Biological Significance of Immunosuppressive Peptide D2702.75–84(E → V) Binding Protein

  1998cites this paper
• Direct binding of the MHC class I molecule H-2Ld to CD8: interaction with the amino terminus of a mature cell surface protein.

  1998cites this paper
• Purified truncated recombinant HLA-B7 molecules abrogate cell function in alloreactive cytotoxic T lymphocytes by apoptosis induction.

  1998cites this paper
• Terminus of a Mature Cell Surface Protein to CD 8 : Interaction with the AminodH-2 L Direct Binding of the MHC Class I Molecule

  1998cites this paper
• Soluble HLA class I molecules: biological significance and clinical implications.

  1998cites this paper
• Soluble HLA: a review of the literature.

  1998cites this paper
• Foreign peptides expressed in engineered chimeric self molecules.

  1998cites this paper
• Split tolerance to the MHC class I molecule H-2Dd in animals transgenic for its soluble analog.

  1997cites this paper
• Prevention of Transplant Rejection

  1997cites this paper
• Interleukin-2 Activated Lymphocytes Use CD11B/CD18 for Adhesion to Candida Albicans

  1997cites this paper
• Prevention of transplant rejection: current treatment guidelines and future developments.

  1997cites this paper
• Immunosuppression by D-isomers of HLA class I heavy chain (amino acid 75 to 84)-derived peptides is independent of binding to HSC70.

  1997cites this paper
• Quantitative cytometry of MHC class I digestion from living cells.

  1997cites this paper
• Treatment with an HLA-peptide and cyclosporine A prolongs rat small bowel allograft survival.

  1997cites this paper
• Why do we reject a graft? Mechanisms of recognition of transplantation antigens

  1996cites this paper
• Natural killer clones recognize specific soluble HLA class I molecules

  1996cites this paper
• Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses

  1996cites this paper
• Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.

  1996cites this paper
• Biophysical studies of T-cell receptors and their ligands.

  1996cites this paper
• Cooperative Recognition of MHC Class II:Peptide Complexes by the T Cell Receptor and CD4

  1996cites this paper
• Specificity and binding properties of a single-chain T cell receptor.

  1996cites this paper
• Synthetic Peptides Derived from Human MHC Class I Sequences Delay Allograft Rejection in Rodents and Inhibit Cell‐Mediated Cytotoxicity In Vivo and In Vitro

  1996cites this paper
• In vitro studies during long term oral administration of specific transfer factor

  1996cites this paper
• Biochemical and immunological evaluation of donor-specific soluble HLA in the circulation of liver transplant recipients.

  1996cites this paper
• A high affinity T cell receptor?

  1996cites this paper
• Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity.

  1996cites this paper
• Indirect allorecognition of HLA class I peptides by CD4+ cytolytic T lymphocytes.

  1996cites this paper
• Studying interactions involving the T-cell antigen receptor by surface plasmon resonance.

  1996cites this paper
• Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex.

  1996cites this paper
• Missing T-cell receptor V beta families following blood transfusion. The role of HLA in development of immunization and tolerance.

  1995cites this paper
• Prolongation of skin allograft survival in mice following administration of ALLOTRAP.

  1995cites this paper
• Soluble HLA Class I and Class II Concentrations in Factor VIII and PCC Preparations

  1995cites this paper
• Donor human leukocyte antigens in the circulation of liver allograft recipients

  1995cites this paper
• Production of soluble HLA-class-I molecules by IFN-gamma-induced colon-adenocarcinoma cells.

  1995cites this paper
• A synthetic dimeric HLA class I peptide inhibits T cell activity in vitro and prolongs allogeneic heart graft survival in a mouse model.

  1995cites this paper
• Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.

  1995cites this paper
• Measuring interactions of MHC class I molecules using surface plasmon resonance.

  1995cites this paper
• Immunosuppressive peptides corresponding to MHC class I sequences.

  1995cites this paper
• Production of soluble HLA‐class‐I molecules by IFN‐γ‐induced colon‐adenocarcinoma cells

  1995cites this paper
• Section Review—Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Trials and Tribulations in the Development of Antigen-Specific Therapies for Rheumatoid Arthritis

  1995cites this paper
• Immunomodulation by soluble HLA class I.

  1995cites this paper
• Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation.

  1995cites this paper
• Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A.

  1994cites this paper
• Inhibition of Alloreactive Cytotoxic T Cell Activity by HIV-Positive Sera: Potential Role of Circulating Soluble HLA Class I Molecules

  1994cites this paper
• The V beta complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex

  1994cites this paper
• Mechanisms of T cell recognition of alloantigen. The role of peptides.

  1994cites this paper
• T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity.

  1994cites this paper
• HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection.

  1994cites this paper
• Selective events in T cell development.

  1994cites this paper
• The induction of tolerance to alloantigens using HLA-based synthetic peptides.

  1994cites this paper
• Bioengineered soluble HLA-B7. Genesis, characterization, and occurrence of dimerization.

  1994cites this paper
• A polymerase chain reaction-based enzyme-linked immunosorbent assay for relative quantitation of T cell receptor beta-gene expression. Its application to the analysis of T cell receptor repertoire usage in alloreactive responses.

  1994cites this paper
• T cell influence on superantigen-induced arthritis in MRL-lpr/lpr mice.

  1994cites this paper
• Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists.

  1994cites this paper
• Determinant selection of major histocompatibility complex class I- restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues

  1994cites this paper
• T cells in autoimmunity and allograft rejection.

  1994cites this paper
• Interaction of papain‐digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL)

  1993cites this paper
• Quantitation and characterization of plasma HLA in neonates of different gestational ages.

  1993cites this paper
• HLA class I soluble antigens serum levels in liver transplantation

  1993cites this paper
• The soluble pool of beta 2-microglobulin free HLA class I alpha-chains. Qualitative and quantitative characterization.

  1993cites this paper
• Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.

  1993cites this paper